Meta-Analysis the Effect of Chlorhexidine and Povidone Iodine Mouthwashes on Viral Load SARS-CoV-2-Saliva
Abstract
Background: The strategy to reduce the risk of transmission of COVID-19 is to reduce the salivary SARS-CoV-2 viral load. Chlorhexidine and povidone iodine mouthwash are common active ingredients in oral antiseptics that have efficient viral activity against salivary SARS-CoV-2. This study aims to combine the results of several effect sizes regarding the effect of using chlorhexidine and povidone iodine mouthwash on the salivary SARS-CoV-2 viral load from various countries.
Subject and Method: This study is a meta-analysis with the following PICO model, P: COVID-19 patients. I: use of chlorhexidine and povidone iodine mouthwash. C: no mouthwash. O: salivary SARS-CoV-2 viral load. A search for the articles used in this study was carried out using the keywords “COVID-19” OR “SARS-CoV-2” OR “viral load” OR “SARS-Cov-2 viral load” OR “Chlorhexidine mouthrinse” OR “Povidone Iodine mouthrinse ” OR “Randomized Controlled Trial” OR “RCT” between 2012-2022 from the PubMed, Springerlink, Elsevier, Google Scholar and Wiley Online Library databases. The inclusion criteria used in this study were full-text articles using a Randomized Controlled Trial (RCT) design. The analysis used was multivariate with Standardized Mean Difference (SMD). The articles collected were then critically reviewed using the PRISMA checklist, then the data were analyzed using the Review Manager 5.4 tool.
Results: This meta-analysis examined 10 articles with a Randomized Controlled Trial (RCT) study design originating from Singapore, Saudi Arabia, Iran, Brazil, Italy, South Korea and Malaysia. A meta-analysis of 7 articles showed that the use of chlorhexidine mouthwash could reduce salivary SARS-CoV-2 viral load by 0.12 units lower than without the use of mouthwash (SMD= -0.12; 95% CI= -0.33 to 0.09; p=0.250). Meanwhile, 7 articles showed that the use of povidone iodine mouthwash could reduce the salivary SARS-CoV-2 viral load by 0.64 units lower than without the use of mouthwash (SMD= -0.64; 95% CI= -1.51 to 0.23; p=0.150).
Conclusion: The use of chlorhexidine and povidone iodine mouthwashes can reduce the amount of salivary SARS-CoV-2 viral
Keywords: mouthwash, chlorhexidine, povidone iodine, COVID-19, salivary SARS-CoV-2 viral load.
Correspondence: Danti Narulita. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Jawa Tengah. Email: dantinarulita@yahoo.co.id. Mobile: +6282158818400.
Indonesian Journal of Medicine (2022), 07(04): 387-400
https://doi.org/10.26911/theijmed.2022.07.04.04
References
Alzein R, Sater FA, Fakhreddine S, Hanna PA, Feghali R, Hamad H, Ayoub F (2021). In vivo evaluation of the virucidal efficacy of chlorhexidine and povidoneiodine mouthwashes against Salivary Sarscov2. A randomizedcontrolled clinical trial. J Evid Base Dent Pract. 21(3): 110. Doi: 10.1016/j.jebdp.2021.101584.
Chopra A, Sivaraman K, Radhakrishnan R, Balakrishnan D, Narayana A (2021). Can povidone iodine gargle/mouthrinse inactivate SarsCov2 and decrease the risk of nosocomial and community transmission during the Covid19 pandemic? an evidencebased update. Jpn Dent Sci. 57: 39–45. Doi: 10.1016/j.jdsr.2021.03.001.
Costa DD, Brites C, Vaz SN, Santana DS, Santos JN, Cury PR (2021). Chlorhexidine mouthwash reduces the salivary viral load of SARSCoV2: A randomized clinical trial. Oral Dis.1: 19. Doi: 10.1111/odi.14086.
Eduardo FP, Corrêa L, Heller D, Daep CA, Benitez C, Malheiros Z, Stewart B, et al. (2021). Salivary SARSCoV2 load reduction with mouthwash use: A randomized pilot clinical trial. Heliyon. 7(6): 17. Doi: 10.1016/j.heliyon.2021.e07346.
Fang F, Chen Y, Zhao D, Liu T, Huang Y, Qiu L (2020). Recommendations for the diagnosis, prevention, and control of coronavirus disease19 in children the chinese perspectives. Front Pediatr. 8(11): 116. Doi: 10.3389/fped.2020.553394.
Fantozzi PJ, Pampena E, Pierangeli A, Oliveto G, Sorrentino L, Vanna DD, Pampena R, et al. (2022). Efficacy of antiseptic mouthrinses against SARSCoV2: A prospective randomized placebocontrolled pilot study. Am J Otolaryngol. 43(6): 16. Doi: 10.1016/j.amjoto.2022.103549. Ferrer MD, Barrueco AS, Beneyto YM, Moreno MVM, Marquez VA, Vazquez EG, Torres MP, et al. (2021). Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS CoV 2. Sci.Rep. 11(24392): 19. Doi: 10.1038/s4159802103461y.
Ghasemi S, Nadji SA, Heidari A, Jeffery JN, Galougahi MK, Raygani N, Khazaei S, et al. (2022). Reduction in SARSCoV2 oral viral load with prophylactic mouth rinse. Eur J Gen Dent. 01:172. Doi: 10.1055/s00421747958.
Lamas ML, Dios PD, Rodriguez MTP, Perez VDC, Alvargonzalez JJC, Perez VDC, Alvargonzalez JJC, et al. (2020). Is povidone iodine mouthwash effective against SARSCoV2? First in vivo tests. Oral Dis. 28(1): 908911. Doi: 10.1111/odi.13526.
Mukhtar K, Qassim S, Qahtani SA, Danjuma M, Mohamedali M, Alfarhan H, Khudair MF, et al. (2020). A randomized trial on the regular use of potent mouthwash in COVID19 treatment. medRxiv. Doi: 10.1101/2020.11.27.20234997.
Murti B (2018). Prinsip dan metode riset epidemiologi (Epidemiological research principles and methods). Edisi V. Bintang Fajar Offset Colomadu
Natto ZS, Bakhrebah MA, Afeef M, Alharbi S, Nassar MS, Alhetheel AF, Ashi H (2022). The shortterm effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARSCoV2 viral load An open label randomized controlled clinical trial study. Medicine. 101(30): 15. Doi: 10.1097/MD.0000000000028925.
Seneviratne CJ, Balan P, Ko KK, Udawatte NS, Lai D, Ng HL, Venkatachalam I, et al. (2021). Efficacy of commercial mouthrinses on SarsCov2 viral load in saliva: Randomized control trial in Singapore. Singapore Med J SINGAP MED J. 49(2): 305–311. Doi: 10.1007/s15010020015639.
Singh GP, Vivekanand L, Roy P (2021). Effect of preprocedural oral rinses with active ingredients like chlorhexidine, povidoneiodine and cetylpyridinium chloride in neutralizing SARSCOV2 concentration in aerosol. GSC Adv Res Rev. 06(03): 132–135. Doi: 10.30574/gscarr.2021.6.3.0048.
To KW, Yin OT, Yip CY, Chan KH, Wu TC, Chan MC, et al. (2020). Consistent detection of 2019 Novel Coronavirus in saliva. Clin Infect Dis. 71(15): 841–843. Doi: 10.1093/cid/ciaa149.
WHO Varian COVID. https://www.who.int/en/activities/trackingSARSCoV2variants/ accessed date 19 Maret 2022
Xu H, Zhong L, Deng J, Peng JH, Zeng X, Li T, et al. (2020). High expression of ACE2 receptor of 2019nCoV on the epithelial celss of oral mucosa. Int. J. Sci. 12(8): 15. Doi: 10.1038/s413680200074x.
Yoon JG, Yoon J, Song JY, Yoon SY, Lim CS, Seong H, Noh JY, et al. (2020). Clinical significance of a high SarsCoV2 viral load in the saliva. J Korean Med Sci. 35(20): 1–6. Doi: 10.3346/JKMS.2020.35.E195.
